Recombinant Xenopus tropicalis Autophagy-related protein 13 (atg13), partial

What is ATG13 and what is its role in autophagy?

ATG13 is an essential autophagy factor required for autophagosome formation and mitophagy. It functions as a target of the TOR kinase signaling pathway, which regulates autophagy through phosphorylation of ATG13 and ULK1, and through the regulation of the ATG13-ULK1-RB1CC1 complex . The protein is critically involved in the early stages of autophagy, serving as an adaptor protein by recruiting ULK1, RB1CC1, and ATG101 to form a core ULK1 complex that initiates autophagosome formation . Through regulation of ULK1 activity, ATG13 also plays a role in modulating mTORC1 kinase activity and cell proliferation .

Why is Xenopus tropicalis used as a model organism for ATG13 research?

Xenopus tropicalis provides several advantages as a model organism for studying ATG13:

• It possesses a diploid genome, in contrast to the allotetraploid genome of Xenopus laevis, making genetic studies more straightforward .

• The X. tropicalis genome has been fully sequenced, facilitating genomic and transcriptomic analyses .

• Its repertoire of transcription factors and regulatory networks is highly comparable to those of humans and mice, with approximately 1,235 genes encoding DNA-binding transcription factors .

• X. tropicalis has well-established developmental biology research protocols, making it valuable for studying developmentally regulated processes like autophagy.

What are the key structural features of ATG13?

ATG13 contains several critical structural domains that facilitate its function:

• N-terminal phospholipid-binding motif: Contains four conserved amino acid residues that mediate interaction with phosphatic acid (PA), phosphatidylinositol 3-phosphate (PtdIns3P), phosphatidylinositol 4-phosphate (PtdIns4P), and to a lesser extent with phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) .

• HORMA domain: Present in the N-terminal region of the protein .

• Intrinsically disordered C-terminal region: Contains interaction sites for ULK1 and RB1CC1 . In human ATG13, the sequence V348-M373 has been identified as the RB1CC1 interaction site .

• ATG101 binding region: Critical for autophagy function, as the interaction between ATG13 and ATG101 has been identified as having the strongest influence on autophagy induction .

• Multiple phosphorylation sites: ATG13 is a serine-rich protein containing several phosphorylation sites that are targets for regulation by kinases such as TOR .

How do mutations in the phospholipid-binding domain of X. tropicalis ATG13 affect autophagy dynamics?

Mutations in the phospholipid-binding domain of ATG13 have significant effects on autophagy dynamics. Research indicates that four key amino acid residues in the N-terminal phospholipid-binding motif are essential for interaction with various phospholipids . When these residues are mutated, several consequences occur:

• Severe decrease in phospholipid binding capacity

• Inhibition of ATG13 translocation to the autophagosome formation site

• Impeded autophagic flux upon starvation

The phospholipid-binding capability appears to be evolutionarily conserved and enables ATG13 to associate with membrane structures, facilitating the recruitment of the ULK1 complex to the site of autophagosome formation. While disrupting this binding has a measurable impact on autophagy, research suggests the effect is relatively mild compared to disrupting protein-protein interactions within the ULK1 complex, particularly the ATG13-ATG101 interaction .

What are the differences in ATG13-mediated autophagy regulation between amino acid starvation and MTOR inhibition?

Research demonstrates distinct differences in ATG13-mediated autophagy regulation depending on the inducing stimulus:

• Response intensity: The effects of disrupting ATG13 interactions are generally more pronounced when autophagy is induced by MTORC1/2 inhibition compared to amino acid starvation .

• Pathway dependency: Amino acid starvation using EBSS (Earle's Balanced Salt Solution) might induce autophagy partially independent of the MTOR-ULK1 axis, explaining the milder effects observed when ATG13 interactions are disrupted under starvation conditions .

• Complex reorganization: During MTOR inhibition, the ATG13-ULK1-RB1CC1 complex undergoes specific conformational changes and recruitment patterns that differ from those observed during amino acid starvation .

This differential response highlights the complexity of autophagy regulation and suggests that multiple pathways converge on the autophagy machinery, with the ULK1 complex serving as a central hub for integration of various signals.

How does the ATG13-ATG101 interaction influence ULK1 complex formation and stability?

The interaction between ATG13 and ATG101 appears to be central to ULK1 complex formation and autophagy induction . Studies targeting various interactions within the ULK1 complex have found that disrupting the ATG13-ATG101 interaction shows the strongest autophagy-inhibitory effect . This suggests that ATG101 plays a critical stabilizing role within the complex.

Mechanistically, ATG101 likely:

• Protects ATG13 from proteasomal degradation

• Facilitates proper folding of ATG13

• Enhances the recruitment of downstream autophagy factors

The significance of this interaction is particularly evident in experiments showing that mutations interfering with ATG13-ATG101 binding lead to more severe autophagy defects than mutations disrupting ATG13-ULK1 or ATG13-RB1CC1 interactions .

What are the optimal conditions for expressing recombinant X. tropicalis ATG13 protein?

Based on current research protocols for recombinant protein expression, the following conditions are recommended for X. tropicalis ATG13 expression:

Expression System Options:

Recommended Protocol for E. coli Expression:

• Clone partial ATG13 (avoiding intrinsically disordered regions if possible)

• Transform into BL21(DE3) E. coli

• Induce with 0.5 mM IPTG at OD600 of 0.6-0.8

• Express at 18°C overnight to promote proper folding

• Purify using affinity chromatography with appropriate tags (His6, GST, or MBP tags can improve solubility)

For functional studies requiring full post-translational modifications, insect or mammalian expression systems may be preferred despite lower yields.

What methods are effective for studying ATG13 phosphorylation states?

ATG13 is a serine-rich protein containing multiple phosphorylation sites that are regulated by TOR kinase signaling . Effective methods for studying these phosphorylation states include:

• Phospho-specific antibodies: Develop or acquire antibodies that recognize specific phosphorylated residues of ATG13. These can be used in Western blotting, immunoprecipitation, or immunofluorescence.

• Phos-tag SDS-PAGE: This technique uses Phos-tag molecules in polyacrylamide gels to specifically retard the migration of phosphorylated proteins, allowing separation of differently phosphorylated forms of ATG13.

• Mass spectrometry:

  • Use phospho-enrichment techniques (TiO2 beads, IMAC)

  • Perform LC-MS/MS analysis to identify phosphorylated peptides

  • Quantify phosphorylation stoichiometry using label-free or isotope labeling approaches

• In vitro kinase assays: Purified recombinant ATG13 can be used as a substrate for TOR or other kinases to study phosphorylation dynamics.

• Phosphomimetic and phospho-deficient mutants: Generate ATG13 variants where key serine/threonine residues are replaced with aspartate/glutamate (phosphomimetic) or alanine (phospho-deficient) to study the functional impact of phosphorylation.

How can researchers effectively analyze ATG13 interactions with the ULK1 complex components?

Several methodologies can be employed to study ATG13 interactions with ULK1, RB1CC1, and ATG101:

• Co-immunoprecipitation (Co-IP): This classical approach can identify protein-protein interactions in cell lysates. Using antibodies against ATG13 or other complex components, researchers can isolate the complex and identify interacting partners by Western blotting.

• Proximity Ligation Assay (PLA): This technique allows visualization of protein-protein interactions in situ with high sensitivity and specificity. It can detect endogenous proteins without overexpression.

• Yeast Two-Hybrid (Y2H): Though classical, this approach can map specific interaction domains. Research has used Y2H to identify that the last 3 amino acids of ATG13 are indispensable for ULK1 binding .

• Bimolecular Fluorescence Complementation (BiFC): By fusing split fluorescent protein fragments to potential interaction partners, researchers can visualize interactions in living cells.

• Surface Plasmon Resonance (SPR) or Isothermal Titration Calorimetry (ITC): These biophysical methods can quantitatively measure binding affinities and kinetics using purified recombinant proteins.

• Domain mapping through truncation/deletion mutants: Studies have identified that:

  • The sequence V348-M373 represents the RB1CC1 interaction site in ATG13

  • The last 3 amino acids of ATG13 are critical for ULK1 binding

  • Using similar approaches, researchers can map interaction domains in X. tropicalis ATG13

How should researchers interpret changes in ATG13 localization patterns during autophagy?

ATG13 localization is a key indicator of autophagy dynamics. Proper interpretation of localization patterns should consider:

• Basal conditions: Under nutrient-rich conditions, ATG13 typically shows diffuse cytoplasmic distribution with some perinuclear accumulation alongside RB1CC1 .

• Upon autophagy induction: ATG13 and RB1CC1 form co-localizing punctate structures that represent the autophagosome formation site .

• Interpretation guidelines:

  • Puncta formation indicates active autophagy initiation

  • Co-localization with other ULK1 complex components (particularly RB1CC1) confirms functional complex assembly

  • Failure to form puncta despite autophagy induction suggests defects in complex assembly or recruitment

  • Altered dynamics of puncta formation/dissolution may indicate modified autophagy kinetics

• Quantification approaches:

  • Count the number of ATG13-positive puncta per cell

  • Measure the size of puncta

  • Assess co-localization with other markers (e.g., WIPI2, ATG16L1) using Pearson's correlation coefficient

  • Track puncta formation over time using live-cell imaging

What are the key considerations when analyzing ATG13 evolutionary conservation across species?

When analyzing evolutionary conservation of ATG13, researchers should consider:

What are common challenges in purifying recombinant X. tropicalis ATG13 and how can they be addressed?

Purification of recombinant ATG13 presents several challenges due to its structural characteristics:

• Protein solubility issues:

  • Challenge: The intrinsically disordered C-terminal region of ATG13 can lead to aggregation and insolubility.

  • Solution: Express the protein at lower temperatures (16-18°C), use solubility-enhancing tags (MBP, SUMO), or consider expressing only structured domains separately.

• Proteolytic degradation:

  • Challenge: The disordered regions of ATG13 are susceptible to proteolysis.

  • Solution: Add protease inhibitors throughout purification, minimize purification time, and consider purifying at 4°C.

• Co-purification of interacting partners:

  • Challenge: ATG13's multiple interaction sites may lead to co-purification of bacterial proteins.

  • Solution: Use stringent washing conditions and multi-step purification approaches.

• Phosphorylation heterogeneity:

  • Challenge: When expressed in eukaryotic systems, ATG13 may exhibit heterogeneous phosphorylation patterns.

  • Solution: Use phosphatase treatment to obtain homogeneously dephosphorylated protein, or use specific expression conditions to promote uniform phosphorylation.

• Expression optimization strategy:

How can researchers effectively validate ATG13 knockout or knockdown models?

Proper validation of ATG13 knockout or knockdown models is essential for interpreting experimental results. A comprehensive validation approach should include:

• Genetic validation:

  • PCR genotyping to confirm genetic modifications

  • Sequencing of the targeted locus to verify introduced mutations

  • For CRISPR/Cas9 approaches, assessment of potential off-target effects

• Protein-level validation:

  • Western blotting to confirm complete absence (knockout) or reduction (knockdown) of ATG13 protein

  • Immunofluorescence to verify loss of ATG13 localization patterns

• Functional validation:

  • Assessment of autophagy markers (LC3-II formation, p62 degradation)

  • Analysis of ULK1 complex formation and localization

  • Monitoring autophagosome formation using transmission electron microscopy

• Complementation assays:

  • Re-expression of wild-type ATG13 should rescue autophagy defects

  • Domain mutants can be used to confirm specific functional roles

• Specificity controls:

  • Monitor expression of other autophagy genes to ensure specific effects

  • Assess both basal and induced autophagy under different conditions (amino acid starvation, MTOR inhibition)

What are emerging research areas for X. tropicalis ATG13 in developmental biology?

Xenopus tropicalis, as a model organism with a well-sequenced genome and established developmental biology protocols, offers unique opportunities for studying ATG13 in developmental contexts:

• Developmental regulation of autophagy:

  • Investigating stage-specific expression patterns of ATG13 during embryogenesis

  • Determining how maternal-to-zygotic transition affects ATG13 function

  • Studying tissue-specific roles of ATG13 during organogenesis

• Cellular remodeling during metamorphosis:

  • Examining how ATG13-mediated autophagy contributes to tissue remodeling during amphibian metamorphosis

  • Investigating hormonal regulation of ATG13 activity during development

• Comparative studies with X. laevis:

  • Analyzing functional differences between ATG13 in diploid (X. tropicalis) versus allotetraploid (X. laevis) species

  • Determining if gene duplication in X. laevis has led to subfunctionalization of ATG13

• Developmental stress responses:

  • Exploring how environmental stressors affect ATG13-dependent autophagy during development

  • Investigating the relationship between developmental timing and autophagy activation

• Transgenic approaches:

  • Development of fluorescently tagged ATG13 transgenic lines for in vivo imaging

  • CRISPR/Cas9-mediated generation of ATG13 mutants to study developmental consequences

How might species-specific differences in ATG13 structure influence autophagy regulation?

Species-specific differences in ATG13 structure may have significant implications for autophagy regulation:

• Intrinsically disordered regions (IDRs):

  • The C-terminal IDR of ATG13 shows greater sequence divergence across species compared to structured domains

  • These differences may influence binding partner interactions and complex formation kinetics

  • IDRs often serve as regulatory hubs through post-translational modifications, and species-specific differences may reflect adaptation to different regulatory networks

• Interaction domains:

  • While core autophagy machinery is conserved, specific interaction interfaces may show subtle species-specific adaptations

  • These differences could affect complex stability and the dynamics of autophagosome formation

• Phosphorylation sites:

  • The number and positioning of phosphorylation sites in ATG13 may vary between species

  • This could lead to differences in how autophagy responds to nutrient signaling and other regulatory inputs

• Splice variants:

  • Different species may express different ATG13 isoforms

  • Research has identified an ATG13 isoform in DT40 chicken B-lymphocyte cell line missing a 26-amino-acid stretch encoded by exon12, which cannot bind to RB1CC1

  • Similar species-specific splice variants might exist in X. tropicalis

• Codon usage bias:

  • Studies have shown that ATG13 genes across different eukaryotic species display specific patterns in nucleotide and synonymous codon usage

  • These differences may influence translation efficiency and protein expression levels, potentially affecting autophagy regulation

What are the most promising applications of recombinant X. tropicalis ATG13 in autophagy research?

Recombinant X. tropicalis ATG13 offers several valuable applications in autophagy research:

• Structural studies: The availability of purified protein enables detailed structural analysis through X-ray crystallography or cryo-EM, particularly of the more structured N-terminal regions.

• Interaction screening: Recombinant ATG13 can be used in pull-down assays or protein arrays to identify novel interaction partners, potentially uncovering amphibian-specific autophagy regulators.

• Antibody development: Purified protein serves as an excellent antigen for generating specific antibodies that recognize X. tropicalis ATG13, facilitating developmental studies in this model organism.

• In vitro reconstitution: Combining purified ATG13 with other autophagy components allows reconstitution of complex formation and early autophagy events in a controlled setting.

• Drug screening: The protein can be used in binding or activity assays to screen for compounds that modulate ATG13 function, potentially identifying novel autophagy regulators.

• Comparative studies: Side-by-side analysis with ATG13 from other species can reveal evolutionary adaptations and conserved mechanisms in autophagy regulation.